The latest trading day saw Merck (MRK) settling at $98.82, representing a -0.13% change from its previous close.

Kennedy’s commitment to walk away from the potential windfall is a major reversal for the nominee, who in his ethics plan ...

Kennedy vowed to divest his financial interest in vaccine litigation to his son. Democrats and ethics experts said the arrangement raised further questions.

Kennedy Jr.'s confirmation hearings to serve as the nation's top health official play out on Capitol Hill, President Trump's ...

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

Robert F. Kennedy Jr., President Trump’s nominee for Health and Human Services secretary, told senators Friday he will divest ...

Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

Merck (NYSE:MRK) has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...

Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...